BOSTON, Feb. 6, 2012 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that Ramita Tandon, Global Head, Late Phase Clinical Trials and Lars-Olof Eriksson, Ph.D., MS.c., Vice President, Global Research Operations at PAREXEL will address innovative approaches to late stage development at the Summit for Clinical Ops Executives ( SCOPE), to be held February 7-9, 2012 in Miami, Florida. Attendees can learn about customized strategic and scientific solutions, provided by the PAREXEL PACE™ (Peri-Approval Clinical Excellence) group, to facilitate the transition from product development to commercialization in a seamless and cost-effective manner, by visiting the PAREXEL Booth #38 on the exhibit floor.
During SCOPE, Ms. Tandon will provide opening remarks for the session entitled "Electronic Health Records and Clinical Trials." The session, which will be held on Tuesday, February 7 at 8:15 a.m., includes presentations from Pfizer, Incyte Corporation, and the Medicines and Healthcare products Regulatory Agency (MHRA).
Other program sessions being presented by PAREXEL experts include:
Tuesday, February 7, 4:30 p.m. and Wednesday, February 8, 4:20 p.m.
- "New Challenges Call for Innovative Approaches to Patient Recruitment and Retention for Post Marketing Trials," in two interactive breakout discussion groups
- "Conducting Phase IIIB/IV Clinical Trials in a Changing Drug Environment," in the session Utilization of Patient-Level Data and Patient Reported Outcomes in Trials